Article
Exploiting evolutionary trade-offs for posttreatment management of drug-resistant populations.
Proceedings of the National Academy of Sciences of the United States of America - 28 Jul 2020
Melnikov Sergey V, Stevens David L, Fu Xian, Kwok Hui Si, Zhang Jin-Tao, Shen Yue, Sabina Jeffery, Lee Kevin, Lee Harry, Söll Dieter
Abstract excerpt
Antibiotic resistance frequently evolves through fitness trade-offs in which the genetic alterations that confer resistance to a drug can also cause growth defects in resistant cells. Here, through experimental evolution in a microfluidics-based turbidostat, we demonstrate that antibiotic-resistant cells can be efficiently inhibited by amplifying the fitness costs associated with drug-resistance evolution. Using...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
